Sarah Cannon Research Institute — Chattanooga, Tennessee

Sarah Cannon Research Institute is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: HER2 Positive Breast Cancer, MSS, RAS-mutant Colorectal Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute?

Sarah Cannon Research Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute conducted?

Sarah Cannon Research Institute has 4 clinical trials on record, with 1 currently active. Their work covers HER2 Positive Breast Cancer, MSS, RAS-mutant Colorectal Cancer.

Is Sarah Cannon Research Institute accredited by Crixeo Health?

Yes — Sarah Cannon Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.